Giugliani, R.; Harmatz, P.; Jones, S.A.; Mendelsohn, N.J.; Vellodi, A.; Qiu, Y.; Hendriksz, Christian J.; Vijayaraghavan, S.; Whiteman, D.A.H.; PAno, A.
(Elsevier, 2017-09)
OBJECTIVES : This 109-week, nonrandomized, observational study of mucopolysaccharidosis II (MPS II) patients already
enrolled in the Hunter Outcome Survey (HOS) (NCT00882921), assessed the long-term immunogenicity of
...